Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
Authors:
Open Access
- 18 February 2022
- journal article
- research article
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 23 (1) , 1-9
Abstract
Background: Methylation of the promoter at CpG islands is a mechanism of silencing tumor suppressor genes and therefore enhances cancer progression. The study aimed to examine promoter methylation frequencies of five tumor suppressor genes in hepatocellular carcinoma and their implication on the first-year outcome of surgical resection of the tumor. Fifty specimens of hepatocellular carcinoma and the adjacent non-tumorous liver tissue were collected from the surgically resected hepatic tumor. The status of promoter methylation of tumor suppressor genes RASSF1A, CHFR, MGMT, GSTP1, and hMLH1 was investigated using methylation-specific polymerase chain reaction.Results: The frequency of promoter methylation of these tumor suppressors genes (TSG) genes in hepatocellular carcinoma was significantly higher than non-tumorous tissue all, P < 0.05, with a methylation rate of 80% in RASSF1A, 70% in CHFR, 46% in GSTP1, 56% in MGMT, and 10% in hMLH1. Methylation of RASSF1A, CHFR, and MGMT promoter genes was significantly associated with decreased first-year postoperative survival and increased recurrence of hepatocellular carcinoma, P < 0.05.Conclusion: Methylated RASSF1A, CHRF, and MGMT promoters indicated poor prognosis among patients with hepatocellular carcinoma and may serve as potential prognostic indicators in patients with hepatocellular carcinoma.Keywords
This publication has 39 references indexed in Scilit:
- Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular CarcinomaClinical Chemistry, 2008
- Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinomaJournal of Clinical Investigation, 2007
- Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNAClinical Cancer Research, 2007
- A new method for accurate assessment of DNA quality after bisulfite treatmentNucleic Acids Research, 2007
- Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosaJournal of Cancer Research and Clinical Oncology, 2006
- The RASSF1A Isoform of RASSF1 Promotes Microtubule Stability and Suppresses TumorigenesisMolecular and Cellular Biology, 2005
- Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarkerDrug Resistance Updates, 2004
- Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal CancerCancer Research, 2004
- Stapler Transection of the Oesophagus for Bleeding Oesophageal VaricesScandinavian Journal of Gastroenterology, 1983
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973